Among the proteins exploited for targeting purposes, albumin has recently emerged as a promising carrier for diagnostic agents [110]: Nanocoll® and Albures® are two formulations of Technetium-99m (99mTc)-aggregated albumin approved for the diagnosis of cancer and arthritis, while other albumin-based imaging tools are still under clinical and preclinical investigation [28]. Here, ALB is linked to cancer.